2024-11-20 07:19:07
Portfolio Highlights: Clinical and Financing Updates of Anji, AIxplorerBio, Domain, VivaVision, ArrePath, QurAlis and Apeiron
Corporate/ 2023-07-24
Portfolio Highlights: Clinical and Finan...

SHANGHAI,May 26,2022-- As the investment division of Viva Biotech,Viva BioInnovator is committed to being a collaborative platform for Innov...

I-Mab Reports Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab
Corporate/ 2023-07-24
I-Mab Reports Latest Phase 2 Clinical Da...

- Uliledlimab appears safe and well-tolerated as a monotherapy and a combination therapy with toripalimab with no dose limiting toxicity

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release